{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:49:19Z","timestamp":1787068159784,"version":"build-2736575974"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,11,5]]},"DOI":"10.1001\/jama.2019.15702","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:31:08Z","timestamp":1572953468000},"page":"1673","source":"Crossref","is-referenced-by-count":103,"title":["Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia"],"prefix":"10.1001","volume":"322","author":[{"given":"Brian T.","family":"Fisher","sequence":"first","affiliation":[{"name":"Division of Pediatrics Infectious Diseases, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoklis","family":"Zaoutis","sequence":"additional","affiliation":[{"name":"Division of Pediatrics Infectious Diseases, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[{"name":"Division of Pediatric Allergy, Immunology and Bone Marrow Transplant, University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nieder","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Zerr","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Seattle Children\u2019s Hospital, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Wingard","sequence":"additional","affiliation":[{"name":"University of Florida College of Medicine, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Callahan","sequence":"additional","affiliation":[{"name":"Division of Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doojduen","family":"Villaluna","sequence":"additional","affiliation":[{"name":"Children\u2019s Oncology Group, Monrovia, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, City of Hope, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha","family":"Dang","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Esbenshade","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Alexander","sequence":"additional","affiliation":[{"name":"Division of Haematology Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Wiley","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Sinai Hospital of Baltimore, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[{"name":"Division of Haematology Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"joi190113r1","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1182\/blood-2007-05-091942","article-title":"Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia.","volume":"110","author":"Sung","year":"2007","journal-title":"Blood"},{"issue":"12","key":"joi190113r2","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/cid\/cis774","article-title":"Association between corticosteroids and infection, sepsis, and infectious death in pediatric acute myeloid leukemia (AML): results from the Canadian Infections in AML Research Group.","volume":"55","author":"Dix","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"joi190113r3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/cncr.v115:5","article-title":"Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia.","volume":"115","author":"Sung","year":"2009","journal-title":"Cancer"},{"issue":"16","key":"joi190113r4","doi-asserted-by":"publisher","first-page":"e604","DOI":"10.1016\/S1470-2045(15)00197-7","article-title":"Classification of treatment-related mortality in children with cancer: a systematic assessment.","volume":"16","author":"Alexander","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4","key":"joi190113r5","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1542\/peds.2005-1161","article-title":"Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.","volume":"117","author":"Zaoutis","year":"2006","journal-title":"Pediatrics"},{"issue":"9","key":"joi190113r6","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"4","key":"joi190113r7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jpids\/piu074","article-title":"A prospective, international cohort study of invasive mold infections in children.","volume":"4","author":"Wattier","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"4","key":"joi190113r8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia.","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"joi190113r9","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America.","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"joi190113r10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pbc.24847","article-title":"Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients.","volume":"61","author":"Science","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"joi190113r11","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1542\/peds.2008-1158","article-title":"A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.","volume":"123","author":"Zaoutis","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"joi190113r12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ijantimicag.2011.07.008","article-title":"Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief report.","volume":"38","author":"Ngai","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"joi190113r13","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/INF.0b013e3181937fe0","article-title":"Caspofungin for the treatment of pediatric fungal infections.","volume":"27","author":"Fisher","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"joi190113r14","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/INF.0b013e3181af5a15","article-title":"Safety experience with caspofungin in pediatric patients.","volume":"28","author":"Zaoutis","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"35","key":"joi190113r15","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1200\/JCO.2012.42.7161","article-title":"Guideline for the management of fever and neutropenia in children with cancer and\/or undergoing hematopoietic stem-cell transplantation.","volume":"30","author":"Lehrnbecher","year":"2012","journal-title":"J Clin Oncol"},{"issue":"12","key":"joi190113r16","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/590167","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"joi190113r18","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk.","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"1","key":"joi190113r19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/biomet\/74.1.149","article-title":"Design and analysis of group sequential tests based on the type I error spending rate function.","volume":"74","author":"Kim","year":"1987","journal-title":"Biometrika"},{"issue":"3","key":"joi190113r20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/1740774511401636","article-title":"Alternatives to the standard Fleming, Harrington, and O\u2019Brien futility boundary.","volume":"8","author":"Anderson","year":"2011","journal-title":"Clin Trials"},{"issue":"3","key":"joi190113r21","doi-asserted-by":"publisher","first-page":"e0212837","DOI":"10.1371\/journal.pone.0212837","article-title":"A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.","volume":"14","author":"Arrieta","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"joi190113r22","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1093\/annonc\/mdx042","article-title":"Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial.","volume":"28","author":"Lesaffre","year":"2017","journal-title":"Ann Oncol"},{"issue":"4","key":"joi190113r23","doi-asserted-by":"publisher","first-page":"209S","DOI":"10.1016\/0197-2456(89)90059-7","article-title":"Practical problems in interim analyses, with particular regard to estimation.","volume":"10","author":"Pocock","year":"1989","journal-title":"Control Clin Trials"},{"issue":"9","key":"joi190113r24","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/sim.7242","article-title":"Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.","volume":"36","author":"Walter","year":"2017","journal-title":"Stat Med"},{"key":"joi190113r17","unstructured":"InstituteNC. CTEP cancer therapy evaluation program: common terminology criteria for adverse events (CTCAE). https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm. Updated March 1, 2018. Accessed December 31, 2018."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2753898\/jama_fisher_2019_oi_190113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:31:10Z","timestamp":1572953470000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2753898"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":24,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,11,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.15702","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,5]]}}}